Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes.
Poli D, Falsini M, Varano F, Betti M, Varani K, Vincenzi F, Pugliese AM, Pedata F, Dal Ben D, Thomas A, Palchetti I, Bettazzi F, Catarzi D, Colotta V. Poli D, et al. Among authors: falsini m. Eur J Med Chem. 2017 Jan 5;125:611-628. doi: 10.1016/j.ejmech.2016.09.076. Epub 2016 Sep 26. Eur J Med Chem. 2017. PMID: 27721147
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity.
Varano F, Catarzi D, Vincenzi F, Betti M, Falsini M, Ravani A, Borea PA, Colotta V, Varani K. Varano F, et al. Among authors: falsini m. J Med Chem. 2016 Dec 8;59(23):10564-10576. doi: 10.1021/acs.jmedchem.6b01068. Epub 2016 Nov 29. J Med Chem. 2016. PMID: 27933962
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles.
Squarcialupi L, Betti M, Catarzi D, Varano F, Falsini M, Ravani A, Pasquini S, Vincenzi F, Salmaso V, Sturlese M, Varani K, Moro S, Colotta V. Squarcialupi L, et al. Among authors: falsini m. J Enzyme Inhib Med Chem. 2017 Dec;32(1):248-263. doi: 10.1080/14756366.2016.1247060. J Enzyme Inhib Med Chem. 2017. PMID: 28114825 Free PMC article.
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype.
Falsini M, Squarcialupi L, Catarzi D, Varano F, Betti M, Dal Ben D, Marucci G, Buccioni M, Volpini R, De Vita T, Cavalli A, Colotta V. Falsini M, et al. J Med Chem. 2017 Jul 13;60(13):5772-5790. doi: 10.1021/acs.jmedchem.7b00457. Epub 2017 Jun 16. J Med Chem. 2017. PMID: 28590753
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.
Bonardi A, Falsini M, Catarzi D, Varano F, Di Cesare Mannelli L, Tenci B, Ghelardini C, Angeli A, Supuran CT, Colotta V. Bonardi A, et al. Among authors: falsini m. Eur J Med Chem. 2018 Feb 25;146:47-59. doi: 10.1016/j.ejmech.2018.01.033. Epub 2018 Jan 12. Eur J Med Chem. 2018. PMID: 29407972
Development of novel pyridazinone-based adenosine receptor ligands.
Catarzi D, Varano F, Falsini M, Varani K, Vincenzi F, Pasquini S, Dal Ben D, Colotta V. Catarzi D, et al. Among authors: falsini m. Bioorg Med Chem Lett. 2018 May 15;28(9):1484-1489. doi: 10.1016/j.bmcl.2018.03.086. Epub 2018 Mar 30. Bioorg Med Chem Lett. 2018. PMID: 29627261
18 results